Universal Beteiligungs und Servicegesellschaft mbH Buys 14,002 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 335,757 shares of the medical equipment provider's stock after buying an additional 14,002 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.09% of Intuitive Surgical worth $166,290,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in ISRG. Castleark Management LLC increased its stake in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after acquiring an additional 2,990 shares during the last quarter. Arlington Trust Co LLC boosted its position in Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after buying an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC boosted its position in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after buying an additional 78 shares in the last quarter. Ewing Morris & Co. Investment Partners Ltd. acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $454,000. Finally, Whalerock Point Partners LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $209,000. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president directly owned 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 3,298 shares of company stock worth $1,739,171 in the last ninety days. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ISRG shares. Evercore ISI raised their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Barclays reduced their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Citigroup restated a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. BTIG Research raised their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research note on Monday, June 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $4.51 during mid-day trading on Friday, hitting $493.12. The company had a trading volume of 878,178 shares, compared to its average volume of 1,986,628. The firm has a fifty day moving average price of $531.22 and a 200 day moving average price of $535.38. The company has a market capitalization of $176.74 billion, a PE ratio of 68.76, a price-to-earnings-growth ratio of 5.32 and a beta of 1.64. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same period last year, the business earned $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.